Kal Fishman – President & Chief Executive Officer
Mr. Fishman is the inventor of the Morpheus™ technology, which was taken from concept to FDA submission and clearance in approximately eighteen months. Mr. Fishman is a serial entrepreneur in radiation oncology and radiology. Before founding Empyrean, Mr. Fishman was the co-founder and the Chief Technology Officer and Chief Operations Officer of Sensus Healthcare, Inc., a publicly traded company (Nasdaq®: SRTS) specializing in superficial, brachytherapy and intraoperative oncological radiation therapy systems from 2010 to 2020. Before that, he held executive positions at other medical device companies, including GE Healthcare, Siemens Medical Systems, CTI, Elscint, Positron Medical Systems, and Rcadia Medical Imaging. He is a GE-certified Six Sigma DFSS/DMAIC Black Belt. Before that, Mr. Fishman was a senior research and development engineer in the Israeli Air Force R&D Core at the Airborne Intelligence and Cryptography Division. Mr. Fishman holds over ten patents in radiation oncology, radiology, and bioinformatics. He also serves as the Chairman of the Board of Directors.